Latest news from Datamonitor
May 21, 2008Sales and Marketing generics
Cash-strapped governments and patent expiries fuel generics growth The increase in cost-limiting measures used by governments and a constant stream …
BGMA leader plans push for more generic prescribing
May 21, 2008Sales and Marketing generics
The new leader for the UK generics industry has promised to step up its bid to see more off-patent drugs …
Electronic patient records face four-year delay
May 20, 2008Plans to give every NHS Trust in England access to an electronic patient records system have been condemned for raising …
Ask doctors about your treatment, patients told
May 20, 2008Sales and Marketing
Patients would benefit by getting more involved with their treatment, asking questions and raising concerns with their doctors, according to …
European approval for GSK’s bird flu vaccine
May 20, 2008Sales and Marketing
GlaxoSmithKline has won approval from European regulators for the first ever pre-pandemic vaccine. Prepandrix is based on the currently circulating …
Should I stay or should I go?
May 16, 2008Business Services career, planning, recruitment
You have been bored lately. You don't believe you can progress in your career any further at your present company. …
Patient experience to influence hospital payment
May 16, 2008Hospitals could be paid according to the quality of care and how well operations are performed, as part of efforts …
Plavix faces generic challenge in Germany
May 16, 2008Sales and Marketing Germany, generics
Sanofi-Aventis and Bristol-Myers Squibb are feeling the heat from a Swiss drugs company which intends to market a generic version …
Pfizer invests in oncology for future gains
May 16, 2008Research and Development, Sales and Marketing Cancer, Pfizer
Pfizer has named Garry Nicholson as head of its new global oncology unit, a venture the company believes will bring …
Merck plans US sales cut backs
May 16, 2008Sales and Marketing
Merck is to slash its US sales force, making 1,200 redundant by the end of July after the FDA unexpectedly …
Industry calls for ‘zero tolerance’ on European counterfeits
May 16, 2008Manufacturing and Production
European industry body EFPIA has demanded 'zero tolerance' on counterfeit medicines and proposed tough new security rules to combat the …
Latest news from Datamonitor
May 16, 2008Research and Development
Can biologic drugs tackle antibiotic resistance? Antibody-based products present a novel approach to the treatment and prevention of infections, as …
Lipitor in decline as PCTs take control
May 9, 2008Sales of Lipitor dropped more than £50 million in England last year, as the blockbuster cholesterol drug fell victim to …
Frontline yet to be convinced on reform pledges
May 9, 2008A new code of practice for the NHS has been launched which aims to ensure any future reforms to the …
European threat to direct-to-pharmacy controls
May 9, 2008Medical Communications
A European Commission recommendation over a dispute between GlaxoSmithKline and Greek wholesalers spells bad news for manufacturers, according to a …
Latest news from Datamonitor
May 8, 2008Sales and Marketing
Acambis has received a $425 million, ten-year contract from the US Government agency, the Centers for Disease Control and Prevention, …
NHS behind world’s first gene treatment for blindness
May 8, 2008Sales and Marketing
The world's first gene transplant to treat blindness, partly funded by the UK government, has successfully improved the night vision …
Brussels to boost Europe’s R&D with public funds
May 8, 2008Research and Development
The European Commission is due to spend Euro 2 billion of public money to see the continent return to its …
Specialist nurses fear for jobs
April 30, 2008Some specialist nurses say they are under threat of losing their jobs or being downgraded because of NHS cutbacks. The …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
